Social determinants of health (SDoH) can impact the vulnerable pulmonary arterial
hypertension (PAH) population, especially during the COVID‐19 pandemic. Providers' …

The global impacts of pulmonary hypertension (PH) were formally recognised in 1973 at the
1st World Health Organization meeting dedicated to primary pulmonary hypertension, held …

Objective To assess the association of severe pulmonary arterial hypertension (PAH) with
particulate matter< 2.5 μm (pm 2.5) and clinical data in patients with systemic autoimmune …

Outcomes of patients with pulmonary arterial hypertension (PAH) may be associated with
social determinants of health (SDOH) and other baseline patient characteristics. At present …

African Americans (AA) have a higher incidence of pulmonary hypertension (PH) risk factors.
Few studies have examined the racial differences in the prevalence and etiology of PH and …

The Black Lives Matter protests and COVID-19 pandemic have brought widening disparities
experienced by disadvantaged communities of color to the forefront, generating much …

Introduction Mental disorders are common in patients with pulmonary arterial hypertension
(PAH) and contribute to impaired quality of life (QoL). The impact of mental disorders on …

Conflict of interest statements: Dr RJ Bernardo serves on the medical advisory board for
Janssen Pharmaceuticals. Dr VA de Jesus Perez has no conflict of interest to declare …

There is some disagreement surrounding the definition and use of the term “disparity.” 24,
25 For this article, we use the definition provided by Healthy People 2020, which defines …

Introduction People living with HIV (PLHIV) have a higher risk of developing pulmonary
hypertension (PH) with subsequent poorer prognosis. This review aimed to determine the …